相关实验视频

Updated: Jul 17, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

HDAC11:改善癌症治疗的新目标

Yan Liu¹, Xuechao Tong², Weina Hu³

¹First Department of Oncology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110032, Liaoning, China.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|September 2, 2023

概括

基因脱乙酶11 (HDAC11) 对于调节瘤内的基因表达和蛋白质功能至关重要. 准HDAC11显示出克服癌症治疗耐药性和开发新型癌症治疗方法的希望.

科学领域:

分子生物学分子生物学
癌症研究癌症研究
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

基因脱乙酶11 (HDAC11) 是基因表达和蛋白质功能的关键调节剂.
新兴研究强调了HDAC11在各种瘤类型中的重要作用.
了解HDAC11的功能对于推进癌症治疗至关重要.

研究的目的:

在瘤的背景下,审查当前关于HDAC11的知识.
探索HDAC11的监管机制,包括其网络交互.
总结针对癌症治疗和克服治疗耐药性的HDAC11向进展情况.

主要方法:

在瘤中研究HDAC11的文献综述.
对HDAC11的细胞下定位,结构,表达和功能的分析.
检查涉及ncRNA和基质的监管网络.
针对HDAC的治疗策略的评估11.

主要成果:

HDAC11在瘤生物学中表现出多种作用,影响基因表达和蛋白质功能.
涉及ncRNA和特定基质的调节网络调节癌症中的HDAC11活性.
准HDAC11是一个可行的策略,可以提高癌症疗法的疗效.
对于潜在的临床应用,HDAC11抑制剂的开发正在进展.

结论:

HDAC11是瘤发育和进展的一个重要因素.
准HDAC11为新型癌症疗法提供了一个有希望的途径.
对HDAC11临床影响的进一步研究可能会彻底改变癌症治疗策略.

关键词:

乙化乙化是一种癌症癌症癌症癌症药物耐药性药物耐药性药物耐药性功能功能功能功能这是一种HDAC11抑制剂.基因组脱乙酶11 基因组脱乙酶11 监管机制监管机制

更多相关视频

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...